Blanchet PJ - Search Results

1

Idiopathic myoclonus in the oromandibular region during sleep: a possible source of confusion in sleep bruxism diagnosis.

Kato T, Montplaisir JY, Blanchet PJ, Lund JP, Lavigne GJ. Kato T, et al. Among authors: blanchet pj. Mov Disord. 1999 Sep;14(5):865-71. doi: 10.1002/1531-8257(199909)14:5<865::aid-mds1025>3.0.co;2-0. Mov Disord. 1999. PMID: 10495054

2

Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism.

Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Lavigne GJ, et al. Among authors: blanchet pj. Clin Neuropharmacol. 2001 May-Jun;24(3):145-9. doi: 10.1097/00002826-200105000-00005. Clin Neuropharmacol. 2001. PMID: 11391125 Clinical Trial.

3

Chronic Neuroleptic-Induced Parkinsonism Examined With Positron Emission Tomography.

Galoppin M, Berroir P, Soucy JP, Suzuki Y, Lavigne GJ, Gagnon JF, Montplaisir JY, Stip E, Blanchet PJ. Galoppin M, et al. Among authors: blanchet pj. Mov Disord. 2020 Jul;35(7):1189-1198. doi: 10.1002/mds.28046. Epub 2020 Apr 30. Mov Disord. 2020. PMID: 32353194

4

Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal.

Blanchet PJ, Abdillahi O, Beauvais C, Rompré PH, Lavigne GJ. Blanchet PJ, et al. Mov Disord. 2004 Aug;19(8):892-6. doi: 10.1002/mds.20130. Mov Disord. 2004. PMID: 15300653

5

Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects.

Blanchet PJ, Popovici R, Guitard F, Rompré PH, Lamarche C, Lavigne GJ. Blanchet PJ, et al. Mov Disord. 2008 Oct 15;23(13):1837-42. doi: 10.1002/mds.22102. Mov Disord. 2008. PMID: 18759358

6

Oral dyskinesia: a clinical overview.

Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Blanchet PJ, et al. Int J Prosthodont. 2005 Jan-Feb;18(1):10-9. Int J Prosthodont. 2005. PMID: 15754887 Review.

7

Diffusion-weighted imaging and magnetization transfer imaging of tardive and edentulous orodyskinesia.

Khiat A, Kuznetsov Y, Blanchet PJ, Boulanger Y. Khiat A, et al. Among authors: blanchet pj. Mov Disord. 2008 Jul 15;23(9):1281-5. doi: 10.1002/mds.22081. Mov Disord. 2008. PMID: 18512744

8

Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

Blanchet PJ, Grondin R, Bédard PJ. Blanchet PJ, et al. Mov Disord. 1996 Jan;11(1):91-4. doi: 10.1002/mds.870110117. Mov Disord. 1996. PMID: 8771074

9

Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates.

Hernandez G, Mahmoudi S, Cyr M, Diaz J, Blanchet PJ, Lévesque D. Hernandez G, et al. Among authors: blanchet pj. Mov Disord. 2019 May;34(5):717-726. doi: 10.1002/mds.27630. Epub 2019 Jan 24. Mov Disord. 2019. PMID: 30675935

10

Proton magnetic resonance spectroscopy study of dyskinesia patients.

Kuznetsov Y, Khiat A, Blanchet PJ, Boulanger Y. Kuznetsov Y, et al. Among authors: blanchet pj. Mov Disord. 2007 May 15;22(7):957-62. doi: 10.1002/mds.21459. Mov Disord. 2007. PMID: 17377925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters